Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Ronde

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Virology|September 1, 1997
A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropismT W Vahlenkamp, E J Verschoor, N N Schuurman, et al.
AIDS (London, England)|November 8, 2001
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strainsJ Goudsmit, G J Weverling, L van der Hoek, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individualsP Reiss, F de Wolf, C L Kuiken, et al.
Lancet (London, England)|February 24, 1990
Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIBG Zwart, J J de Jong, T Wolfs, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
(R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infectionT W Vahlenkamp, A De Ronde, J Balzarini, et al.
Intervirology|January 1, 1987
Two domains within the early coding region of SV40 involved in the transformation of human fibroblastsA de Ronde, C J Sol, M E MacDonald, et al.
Journal of Virological Methods|April 1, 1995
Competitive reverse transcription-polymerase chain reaction for quantitation of feline immunodeficiency virusT W Vahlenkamp, H F Egberink, M J van Eijk, et al.
Vaccine|June 2, 1998
Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infectionW Huisman, J A Karlas, K H Siebelink, et al.
Journal of Virology|January 3, 2001
Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virusA de Ronde, M van Dooren, L van Der Hoek, et al.
Virology|April 1, 1991
Immunodominance and antigenic variation of the principal neutralization domain of HIV-1G Zwart, H Langedijk, L van der Hoek, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Virology|September 1, 1997
A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropismT W Vahlenkamp, E J Verschoor, N N Schuurman, et al.
AIDS (London, England)|November 8, 2001
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strainsJ Goudsmit, G J Weverling, L van der Hoek, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individualsP Reiss, F de Wolf, C L Kuiken, et al.
Lancet (London, England)|February 24, 1990
Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIBG Zwart, J J de Jong, T Wolfs, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1995
(R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infectionT W Vahlenkamp, A De Ronde, J Balzarini, et al.
Intervirology|January 1, 1987
Two domains within the early coding region of SV40 involved in the transformation of human fibroblastsA de Ronde, C J Sol, M E MacDonald, et al.
Journal of Virological Methods|April 1, 1995
Competitive reverse transcription-polymerase chain reaction for quantitation of feline immunodeficiency virusT W Vahlenkamp, H F Egberink, M J van Eijk, et al.
Vaccine|June 2, 1998
Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infectionW Huisman, J A Karlas, K H Siebelink, et al.
Journal of Virology|January 3, 2001
Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virusA de Ronde, M van Dooren, L van Der Hoek, et al.
Virology|April 1, 1991
Immunodominance and antigenic variation of the principal neutralization domain of HIV-1G Zwart, H Langedijk, L van der Hoek, et al.
Pageof 7